Lina Khider

ORCID: 0000-0002-7748-183X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Coronary Interventions and Diagnostics
  • Diagnosis and Treatment of Venous Diseases
  • COVID-19 and healthcare impacts
  • Long-Term Effects of COVID-19
  • Photoacoustic and Ultrasonic Imaging
  • Atrial Fibrillation Management and Outcomes
  • Peripheral Artery Disease Management
  • Cardiac Valve Diseases and Treatments
  • Aortic Disease and Treatment Approaches
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Innovations in Medical Education
  • Ultrasound Imaging and Elastography
  • Central Venous Catheters and Hemodialysis
  • Ultrasound and Hyperthermia Applications
  • Blood Coagulation and Thrombosis Mechanisms
  • Systemic Lupus Erythematosus Research
  • Infectious Aortic and Vascular Conditions
  • Sepsis Diagnosis and Treatment
  • Adipokines, Inflammation, and Metabolic Diseases
  • Aortic aneurysm repair treatments
  • Otitis Media and Relapsing Polychondritis

Paris Cardiovascular Research Center
2018-2025

Université Paris Cité
2019-2025

Inserm
2018-2025

Hôpital Européen Georges-Pompidou
2019-2025

Assistance Publique – Hôpitaux de Paris
2019-2025

Sorbonne Paris Cité
2019-2024

Hôpital Européen
2019-2023

ESPCI Paris
2019-2022

Centre National de la Recherche Scientifique
2019-2022

Centre Hospitalier René-Dubos
2022

Coronavirus disease-2019 (COVID-19), a respiratory disease has been associated with ischemic complications, coagulation disorders, and an endotheliitis. To explore endothelial damage activation-related biomarkers in COVID-19 patients criteria of hospitalization for referral to intensive care unit (ICU) and/or worsening. Analysis angiogenic soluble markers plasma from at admission. Study enrolled 40 consecutive admitted emergency department that fulfilled hospitalization. Half them were...

10.1007/s10456-020-09730-0 article EN other-oa Angiogenesis 2020-05-27

Abstract Rationale COVID-19 ARDS could differ from typical forms of the syndrome. Objective Pulmonary microvascular injury and thrombosis are increasingly reported as constitutive features respiratory failure. Our aim was to study pulmonary mechanics gas exchanges in COVID-2019 patients studied early after initiating protective invasive mechanical ventilation, seeking corresponding pathophysiological biological characteristics. Methods Between March 22 30, 2020 mechanics, exchanges,...

10.1186/s13613-020-00716-1 article EN cc-by Annals of Intensive Care 2020-07-16

Abstract Background Microvascular, arterial and venous thrombotic events have been largely described during severe coronavirus disease 19 (COVID-19). However, mechanisms underlying hemostasis dysregulation remain unclear. Methods We explored two independent cross-sectional cohorts to identify soluble markers gene-expression signatures that discriminated COVID-19 severity outcomes. Results found elevated (s)P-selectin at admission was associated with severity. Elevated sP-selectin predictive...

10.1186/s13613-021-00899-1 article EN cc-by Annals of Intensive Care 2021-07-17

In patients with venous thromboembolism at high risk of recurrence for whom extended treatment direct oral anticoagulants has been indicated, the optimal dose is unknown. We aimed to assess efficacy and safety reduced-dose versus full-dose in anticoagulation indicated. RENOVE was a non-inferiority, investigator-initiated, multicentre, randomised, open-label, blinded endpoint trial done 47 hospitals France. Ambulatory aged 18 years or older acute symptomatic (pulmonary embolism proximal deep...

10.1016/s0140-6736(24)02842-3 article EN cc-by The Lancet 2025-02-27

Background Coronavirus disease 2019 (COVID‐19) is a respiratory associated with thrombotic outcomes coagulation and endothelial disorders. Based on that, several anticoagulation guidelines have been proposed. We aimed to determine whether therapy modifies the risk of developing severe COVID‐19. Methods Results Patients COVID‐19 initially admitted in medical wards 24 French hospitals were included prospectively from February 26 April 20, 2020. used Poisson regression model, Cox proportional...

10.1161/jaha.120.018624 article EN cc-by-nc-nd Journal of the American Heart Association 2021-02-08

Ultrasound localization microscopy (ULM) based on ultrafast ultrasound imaging of circulating microbubbles (MB) can image microvascular blood flows in vivo up to the micron scale. Takayasu arteritis (TA) has an increased vascularisation thickened arterial wall when active. We aimed perform vasa vasorum ULM carotid and demonstrate that provide markers assess TA activity.Patients with were consecutively included assessment activity by National Institute Health criteria: 5 had active (median...

10.1016/j.ebiom.2023.104502 article EN cc-by-nc-nd EBioMedicine 2023-03-07

Background: Coronavirus disease 2019 (COVID-19) has been associated with cardiovascular complications and coagulation disorders. Objectives: To explore clinical biological parameters of COVID-19 patients hospitalization criteria that could predict referral to intensive care unit (ICU). Methods: Analyzing the profiles at admission. Results: Among 99 consecutive fulfilled for hospitalization, 48 were hospitalized in medicine department, 21 first admitted ward department referred later ICU, 30...

10.3389/fmed.2020.586307 article EN cc-by Frontiers in Medicine 2020-11-12

Objective The clinical relevance of antiphospholipid antibodies (aPLs) in COVID‐19 is controversial. This study was undertaken to investigate the prevalence and prognostic value conventional nonconventional aPLs patients with COVID‐19. Methods a multicenter, prospective observational French cohort hospitalized suspected Results Two hundred forty‐nine were COVID‐19, whom confirmed 154 not 95. We found significant increase lupus anticoagulant (LAC) positivity among compared without (60.9%...

10.1002/art.41777 article EN Arthritis & Rheumatology 2021-04-22

D‐dimer is a fragment of crosslinked fibrin resulting from plasmin cleavage clots and hence an indirect biomarker the hemostatic system activation. Early in coronavirus disease 2019 (COVID‐19) pandemic, several studies described coagulation disorders affected patients, including high levels. Consequently, has been widely used not‐yet‐approved indications. Ruling out pulmonary embolism deep vein thrombosis patients with low or intermediate clinical suspicion main application D‐dimer. also to...

10.1002/rth2.12730 article EN cc-by-nc-nd Research and Practice in Thrombosis and Haemostasis 2022-04-01
Stéphane Zuily Benjamin Lefèvre Olivier Sanchez Ombeline Empis de Vendin Guillaume de Ciancio and 95 more Jean‐Benoît Arlet Lina Khider Béatrice Terriat Hélène Greigert Céline Robert Guillaume Louis Albert Trinh-Duc P Rispal Sandrine Accassat Guillaume Thiéry David Montani R. Azarian Nicolas Méneveau Simon Soudet Raphaël Le Mao F. Maurier Vincent Le Moing I. Quéré Cécile Yelnik Nicolas Lefèbvre M. Martinot Maxime Delrue Y. Benhamou Florence Parent Pierre‐Marie Roy Émilie Presles François Goehringer Patrick Mismetti Laurent Bertoletti Patrick Rossignol Françis Couturaud Denis Wahl Nathalie Thilly Silvy Laporte Stéphane Zuily Françis Couturaud François Goehringer Silvy Laporte Patrick Mismetti Émilie Presles Patrick Rossignol Nathalie Thilly Denis Wahl Thomas Lecompte Emmanuel Oger Marie‐Antoinette Sevestre Florence Parent Y. Benhamou Pierre‐Marie Roy Tristan Gigante Morgane Gilg Pierre-Luc Maclot Bénédicte Rossignol Jonathan Udot H Bouteille Andréa Buchmuller Céline Peurière El Mehdi Siaghy Valérie Bouaziz Charlotte Daguin B Grosjean Véronique Saunier Laurence Verger M. Jacquot Nadine Petitpain Martin Charly Laurent Tordella Émilie Presles Guillaume Baronnet Elisabeth Baux Athanase Bénétos Jean-Baptiste Blanvillain Marie Conrad Guilhem Courte Aurélie Cravoisy-Popovic Virginie Dufrost Sébastien Gibot Philippe Guerci Laure Joly Antoine Kimmoun Matthieu Koszutski Alexandrine Larue Bruno Lévy Marie-Reine Losser Mathieu Mattèi Lionel Nace Emmanuel Novy Pierre Perez Jean-Pierre Pertek Camille Rigaux Alexis Sauvage Évelyne Schvoerer Carine Thivilier Lev Volkov Piotr Zieminski

Venous thromboembolism is a major complication of coronavirus disease 2019 (COVID-19). We hypothesized that weight-adjusted intermediate dose anticoagulation may decrease the risk venous COVID-19 patients.In this multicenter, randomised, open-label, phase 4, superiority trial with blinded adjudication outcomes, we randomly assigned adult patients hospitalised in 20 French centers and presenting acute respiratory SARS-CoV-2. Eligible were (1:1 ratio) to receive an prophylactic or fixed-dose...

10.1016/j.eclinm.2023.102031 article EN cc-by-nc-nd EClinicalMedicine 2023-06-01

Carotid plaque vulnerability assessment could guide the decision to perform endarterectomy. Ultrafast ultrasound imaging (UF) can evaluate local flow velocities over an entire 2D image, allowing measurement of wall shear stress (WSS). We aimed at evaluating feasibility WSS in a prospective series patients with carotid stenosis. UF acquisitions, performed linear probe, had effective frame rate 5000 Hz. The velocity was imaged area. computed vector field speed using formula: blood and μ,...

10.1055/a-1060-0529 article EN Ultraschall in der Medizin - European Journal of Ultrasound 2019-12-19

The increased interest in anti-platelet factor 4 (PF4)-heparin complex (anti-PF4/H) antibodies following the COVID-19 pandemic has established them as crucial players immunothrombosis. We aimed to investigate involvement of anti-PF4/H during and after vaccination, particularly patients with systemic inflammatory disease (SID). This retrospective study analyzed presence their ability induce platelet activation without suspected heparin-induced thrombocytopenia (HIT), vaccine-induced immune...

10.1016/j.rpth.2025.102701 article EN cc-by Research and Practice in Thrombosis and Haemostasis 2025-01-01

Abstract Isolated distal deep venous thrombosis (iDDVT) is an infra-popliteal DVT without pulmonary embolism (PE). It a common condition, but its management remains debated. We conducted survey distributed by email to the members of French Society Vascular Medicine, Thrombosis Canada, Swiss Angiology and INVENT-VTE research networks; Our objectives were determine how healthcare professionals specialized in manage iDDVT obtain experts input on design future clinical trial. Participants asked...

10.1007/s11239-025-03091-5 article EN cc-by Journal of Thrombosis and Thrombolysis 2025-04-11
Coming Soon ...